Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

02/02/2022 06:00

Feb 2 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.95               10.42            17.90    
                 (+24.2 pct)         (+3.5 pct)       (+18.5 pct) 
  Operating          3.30                1.63             4.10    
                (+103.0 pct)         (+3.1 pct)       (+62.1 pct) 
  Recurring          4.68                1.65             5.63    
                (+184.5 pct)         (-23.1 pct)      (+54.4 pct) 
  Net                5.25                1.48             5.80    
                (+255.4 pct)         (-8.0 pct)       (+58.4 pct) 
  EPS            126.05 yen           35.47 yen       139.31 yen  
  Ann Div                             20.00 yen        40.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             20.00 yen        40.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T